Full-Time

Warehouse Manager

Medline

Medline

10,001+ employees

Manufacturer and distributor of medical supplies

Compensation Overview

$101k - $152k/yr

+ Bonus and/or incentive eligible

West Jefferson, OH, USA

In Person

Bachelor's

Category
Warehouse & Fulfillment
Required Skills
Inventory Management
Customer Service

Get referred to Medline

See people who can refer or advise you

Requirements
  • Three to five years of supervisory experience with demonstrated ability to support personnel and warehouse employees.
  • Effective communication in group and individual settings, effective writing skills, and demonstrated active listening.
  • Ability to work effectively in multicultural environments and deliver presentations.
  • Ability to handle multiple priorities and extensive time demands with urgency, energy, and stamina.
  • High level of personal integrity.
  • Ability to navigate complex internal and external situations involving multiple decision makers.
  • Demonstrated experience in customer relations and ability to lead work environments that embrace positive employee relations.
  • Ability to become certified as a Certified Designated Representative by the State of Florida when applicable for compliant pharmaceutical operations and handling.
Responsibilities
  • Direct warehouse activities and oversee all aspects of daily production and order fulfillment in support of the Director of Operations.
  • Establish procedures for verifying incoming and outgoing shipments, handling and disposing of materials, and keeping warehouse inventory current.
  • Lead and measure daily processes to ensure order fulfillment and production are completed accurately and on time.
  • Partner with the Director of Operations to resolve daily challenges and ensure timely and accurate order fulfillment.
  • Manage applicable transactions as the Certified Designated Representative and ensure accurate procedures and recordkeeping for compliance with the State of Florida's Pharmacy Practice Act administrative rule.
  • Support local human resource processes, including sourcing and staffing positions, performance management, compensation administration, training, and development.
  • Create a culture that promotes positive employee relations while restricting confidential salary information access to respective supervisors, leads, and hourly employees.
  • Support and oversee daily and ongoing expenses to use financial capital efficiently.
  • Prepare work orders for repairs and requisitions for replacement equipment.
  • Schedule, track, and expedite freight to inter-company and contract distributors.
  • Work with carriers to resolve freight discrepancies.
  • Monitor processes to ensure products move correctly from trailers to racks to shipping.
  • Manage Vendor Managed Inventory.
  • Support local sales representatives and sales leadership in delivering customer service.
  • Provide timely responses to service failures and customer concerns.
  • Support the Director of Operations in resolving customer complaints registered through the OSI process.
  • Monitor work-team activities to ensure safe practices are in place and demonstrated.
  • Monitor the building to ensure proper housekeeping practices.
  • Provide guidance to the safety committee.
Desired Qualifications
  • A Bachelor's Degree is preferred; relevant work experience may be accepted in lieu of the degree.
  • Five years of business experience, including several years in a distribution center environment, is preferred.
  • Certification as a Certified Designated Representative by the State of Florida is preferred when applicable.

Medline Industries designs, produces, and distributes medical supplies for healthcare settings. It combines manufacturing and distribution to control product quality and sell directly to hospitals and other healthcare providers, offering a wide range of Medline-branded and third-party products. Its products include gowns, uniforms, gloves, and other medical consumables, produced and then delivered through a direct-to-provider model. The company differentiates itself with vertical integration that bypasses traditional distributors, a long-standing family-led culture that continued after a 2021 private-equity-led majority investment, and the scale to serve healthcare systems with a broad catalog. The goal is to supply healthcare providers with a comprehensive, high-quality catalog of medical products while expanding market reach and maintaining reliability through direct manufacturing-and-distribution control.

Company Size

10,001+

Company Stage

IPO

Headquarters

Northfield, Illinois

Founded

1966

Get referred to Medline

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 sales rose 11.6% to $7.7 billion, driven by existing customers.
  • Medline booked over 65% of its 2026 new-customer goal by June 2026.
  • Perris opens by mid-2027, adding nearly 5 million square feet in California.

What critics are saying

  • FDA warning letters on June 2 and April 8, 2026 signal systemic quality failures.
  • July 13, 2026 neonatal circuit recall exposes product-safety and liability risk.
  • Tracy fire losses and investigations threaten 2027 margins and customer retention.

What makes Medline unique

  • Medline’s 1910-to-1966 manufacturing-plus-distribution model cuts out middlemen.
  • Family control and Blackstone-Carlyle-Hellman backing sustain patient, long-horizon expansion.
  • California network scale, plus Perris automation, strengthens hospital supply reliability.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Life Insurance

Disability Insurance

401(k) Company Match

Paid Vacation

Paid Sick Leave

Growth & Insights and Company News

Headcount

6 month growth

1%

1 year growth

0%

2 year growth

0%
Benzinga
Sep 8th, 2026
Kaplan Fox urges Medline Inc. (MDLN) investors to contact the firm about possible securities law violations.

Kaplan Fox urges Medline Inc. (MDLN) investors to contact the firm about possible securities law violations. Stock score locked: want to see it? Benzinga Rankings give you vital metrics on any stock - anytime. New York, New York-(Newsfile Corp. - September 8, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. ("Medline" or the "Company") (NASDAQ:MDLN). If you are a Medline investor and have suffered losses, or if you have information that could assist in the Medline investigation, you may CLICK HERE to contact us. You may also contact Kaplan Fox by emailing [email protected] or by calling (646) 315-9003. On June 2, 2026, the Federal Drug Administration ("FDA") published a warning letter dated May 28, 2026 addressed to Medline summarizing "significant violations of Current Good Manufacturing Practice regulations for finished pharmaceuticals[.]" The FDA further states that Medline "failed to thoroughly investigate any unexplained discrepancy or failure of a batch or any of its components to meet any of its specifications." Following this news, the price of Medline stock fell $2.56 per share, or 7.16%, to close at $33.19 per share on June 2, 2026. According to a June 3, 2026 Reuters article, the latest FDA warning letter relates to "violations of manufacturing quality standards" and is "the second such action against the (C) ompany in two months." Further, the Reuters article states that according to the FDA, "the Company failed to thoroughly investigate microbial contamination incidents in finished drug products and also cited inadequate cleaning practices." WHY CONTACT KAPLAN FOX? Kaplan Fox & Kilsheimer LLP is a nationally recognized law firm focused on complex litigation, with offices in New York, Oakland, Los Angeles, Chicago, and New Jersey. Founded in 1956, the firm has spent more than 50 years prosecuting securities, antitrust, and consumer protection actions in federal and state courts nationwide, recovering more than $10 billion for clients and the classes it has represented. Kaplan Fox is widely regarded as one of the nation's premier plaintiffs' securities litigation firms and has received recognition from Chambers and Partners, Benchmark Litigation, Super Lawyers, and Lawdragon. Serving as lead or co-lead counsel in many landmark cases, the firm has secured some of the largest recoveries in the history of securities litigation, including a $2.425 billion recovery on behalf of Bank of America shareholders in In re Bank of America - the largest recovery ever obtained for claims under Section 14(a) of the Securities Exchange Act - $800 million recovered for the Arkansas Teacher Retirement System and other pension funds in ATRS v. Allianz Global Investors, and a $475 million settlement in In re Merrill Lynch. For decades, Kaplan Fox has represented public pension funds, institutional investors, businesses, and individuals in high-stakes litigation. Through its successful advocacy and precedent-setting victories, the firm has helped shape important areas of securities and corporate law while advancing accountability and protecting investor interests. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. Past results do not guarantee future outcomes. If you have any questions about this investigation, please contact: Pamela A. Mayer KAPLAN FOX & KILSHEIMER LLP 800 Third Avenue, 38th Floor New York, New York 10022 (646) 315-9003 [email protected] Laurence D. King KAPLAN FOX & KILSHEIMER LLP 1999 Harrison Street, Suite 1501 Oakland, California 94612 (415) 772-4704 [email protected] Contacting or submitting information to Kaplan Fox & Kilsheimer LLP does not create an attorney-client relationship, nor an obligation on the part of Kaplan Fox to retain you as a client.

American Hospital Association
Sep 8th, 2026
FDA issues highest recall for certain breathing circuits, catheters, spinal cord stimulators.

FDA issues highest recall for certain breathing circuits, catheters, spinal cord stimulators. Sep 08, 2026 - 04:36 PM The Food and Drug Administration has identified Class I recalls of the following products: Hudson RCI Neonatal/Infant Heated Wire Breathing Circuits and certain reprocessed electrophysiology and ultrasound catheters by Medline, and all unused Infinion CX Leads by Boston Scientific. The FDA also issued early alerts for other medical products: certain VentStar Resus Neo hoses by Draeger, and certain convenience kits and IV start kits by AVID Medical. Correction notices were issued for certain Medline convenience kits containing recalled BD ChloraPrep Applicators, as well as Portrait Mobile Monitoring Solutions devices by GE Healthcare. Additionally, voluntary recalls were issued for certain lots of intravenous fluids by American Regent and B. Braun Medical.

GlobeNewswire
Sep 3rd, 2026
Medline announces participation in the Morgan Stanley 24th Annual Global Healthcare Conference.

Medline announces participation in the Morgan Stanley 24th Annual Global Healthcare Conference. September 03, 2026 08:30 ET | Source: Medline Inc. NORTHFIELD, Ill., Sept. 03, 2026 (GLOBE NEWSWIRE) - Medline Inc. ("Medline") (Nasdaq: MDLN) today announced that Jim Boyle, chief executive officer, and Mike Drazin, chief financial officer, are scheduled to present at the Morgan Stanley 24th Annual Global Healthcare Conference in New York, NY, on Tuesday, September 15, 2026, at 12:20pm ET. A webcast of the presentation will be available on the Events page of Medline's Investor Relations website at ir.medline.com. A replay of the webcast will be available on Medline's Investor Relations website for 90 days following the event. About Medline Medline is the largest provider of medical-surgical products and supply chain solutions serving all points of care. Through its broad product portfolio, resilient supply chain and leading clinical solutions, Medline helps healthcare providers improve their clinical, financial and operational outcomes. Headquartered in Northfield, Illinois, the company employs more than 45,000 people worldwide and operates in more than 100 countries. To learn more about how Medline makes healthcare run better, visit www.medline.com. Contacts Investor Relations: Karen King Global Head of Investor Relations Patrick Flaherty Director, Investor Relations Media Relations: Ben Fox Vice President, Corporate Communications (224) 327-9999 [email protected] Recommended reading.

Digital Commerce 360
Aug 18th, 2026
Medline tallies tariff refunds as Q2 sales rise 11.6%.

Medline tallies tariff refunds as Q2 sales rise 11.6%. Brian Warmoth | Aug 18, 2026 2.5 minutes Medical supplies distributor Medline recorded $243 million in tariff refunds during its fiscal year through Q2, helping drive revenue growth even as a California warehouse fire weighed on quarterly profits. Medline Inc. recorded $243 million in net tariff refunds that it realized during its current fiscal year by the end of its Q2. Those funds arrived against the backdrop of an overall net income decline of 58.3% year over year to $139 million for the quarter ended June 27. Despite that decrease, the medical supply company outlined its growth plans for the rest of its fiscal year. In addition, it reported an overall sales increase of 11.6% to $7.7 billion for the same period. Jim Boyle, chief executive officer of Medline, said Q2 reflected "strong execution of our growth strategy" and "operational resilience." What drove Medline sales in Q2? Medline credited existing customer growth and new customer signings from 2025 for its rise in Q2 sales. It noted in an earnings release that the latest total accounted for $89 million of accrued customer repayments. Those were associated with refunds from International Emergency Economic Powers Act (IEEPA) tariffs. Those refunds were processed following the U.S. Supreme Court's ruling in February 2026, which found that IEEPA tariffs were not appropriately authorized. Meanwhile, Medline attributed its drop in income to complications related to a June fire. That disaster damaged one of its distribution centers in California. "We delivered robust top-line growth in the quarter, secured over 65% of our annual goal in total new customer signings during the first half of 2026, and moved swiftly to minimize disruption from the fire at our Tracy, California, distribution center, demonstrating an unwavering commitment to our customers," Boyle said. "At the same time, we are effectively managing a dynamic external environment while investing in strategic initiatives to strengthen our market position and support long-term shareholder value creation." Impact from the Tracy fire on Medline. During Medline's Q2 earnings call, Michael Drazin, the company's chief financial officer, assessed that the "Tracy fire impact is transitory and will have some impact rolling in '27." Looking ahead, he told analysts that he expected to see improvements to the situation. Medline is setting up new California distribution centers based in Tracy and Stockton, adding new automation at those facilities. "Obviously, the operational investments and some of the quality investments will be more permanent in nature and will roll into our base in 2027," Drazin said. At the same time, Medline lowered its guidance for adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) in its full-year 2026 outlook. That outlook fell to a range of $3.3 billion to $3.4 billion from $3.5 billion to $3.6 billion previously. "Our outlook reflects several headwinds, including the Middle East conflict, the Tracy warehouse fire, growth-related operational investments, quality remediation efforts and softness in our retail business," Boyle stated.

PR Newswire
Aug 13th, 2026
MDLN investigation: Kessler Topaz Meltzer & Check, LLP encourages Medline Inc. (NASDAQ: MDLN) investors to contact the firm.

MDLN investigation: Kessler Topaz Meltzer & Check, LLP encourages Medline Inc. (NASDAQ: MDLN) investors to contact the firm. Aug 13, 2026, 18:40 ET RADNOR, Pa., Aug. 13, 2026 /PRNewswire/ - Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities laws by Medline Inc. (NASDAQ: MDLN) on behalf of investors who purchased or acquired Medline Inc. Class A common stock and experienced significant financial losses. Medline Reveals Significant FDA Violations On June 2, 2026, the FDA published a warning letter dated May 28, 2026 addressed to Medline summarizing "significant violations of Current Good Manufacturing Practice regulations for finished pharmaceuticals[.]" Specifically, the FDA letter stated that Medline "failed to thoroughly investigate any unexplained discrepancy or failure of a batch or any of its components to meet any of its specifications." According to a June 3, 2026 Reuters article, the latest FDA warning letter to Medline relates to "violations of manufacturing quality standards" and is "the second such action against the (C) ompany in two months." Further, the Reuters article states that according to the FDA, Medline "failed to thoroughly investigate microbial contamination incidents in finished drug products and also cited inadequate cleaning practices." Why Did Medline's Stock Drop? Following the news of Medline's FDA violations, the company's stock price fell over 7%. Then, on August 5, 2026, Medline's stock price dropped by over 12% in response to the company's second quarter results and lowered full-year adjusted EBITDA guidance. Investors who purchased Medline Inc. (NASDAQ: MDLN) Class A common stock and experienced losses may have legal rights under the federal securities laws. CONTACT KTMC TO DISCUSS YOUR LEGAL RIGHTS: If you purchased or acquired Medline Inc. Class A common stock and have lost money on your investment, please provide your information here: https://www.ktmc.com/mdln-medline-inc-investigation?utm_campaign=hc?utm_source=PR_Newswire&utm_medium=pressrelease&utm_campaign=mdln&mktm=PR You can also contact attorney Jonathan Naji, Esq. by calling (484) 270-1453 or by email at [email protected]. There is no cost or obligation to speak with an attorney. ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP (KTMC): Kessler Topaz Meltzer & Check, LLP (KTMC) is a leading U.S. plaintiff-side law firm focused on securities-fraud class actions and global investor protection. The firm represents individual investors as well as institutions, such as major pension funds, asset managers, and international investors. KTMC has led some of the largest recoveries in securities litigation and has been recognized by peers and the legal media with numerous accolades, including being recognized in Chambers & Partners USA 2026 as a Band 1 Top Firm in Securities and Class Actions, Legal 500's Tier 1 Rankings for Securities and M&A Litigation, The National Law Journal's Plaintiff's Hot List and Trailblazers in Plaintiffs' Law, BTI Consulting Group's Honor Roll of Most Feared Law Firms, The Legal Intelligencer's Class Action Firm of the Year, Lawdragon's Leading Plaintiff Financial Lawyers, and Law360's Titans of the Plaintiffs Bar. The firm operates globally with offices in Pennsylvania and California. KTMC has recovered over $25 billion for our clients and the classes they represent. May be considered attorney advertising in certain jurisdictions. Past results do not guarantee future outcomes. SOURCE Kessler Topaz Meltzer & Check, LLP